Skip to main content
Premium Trial:

Request an Annual Quote

Enzymatics Licenses Enzyme Technology from Massey University Researcher

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enzymatics has licensed technology from a New Zealand research facility that could allow genomic sequencing to be done more cheaply and quickly, Massey University said this week.

The enzyme technology was developed in the laboratory of Wayne Patrick, a senior lecturer in biochemistry at the Institute of Natural Sciences at the university, and involves a new method of engineering ligase by fusing DNA-binding proteins to the ligase enzyme.

The result is a family of "more active and efficient" DNA ligases, the university said in a statement.

Enzymatics, a molecular biology enzyme manufacturing firm, will further develop, manufacture, and market the improved enzymes, Massey University said.

Terms of the deal were not disclosed. Enzymatics, based in Beverly, Mass., did not respond to a request for comment.

Patrick said his research tackles fundamental questions about the evolution of enzyme structure and function. "We used that fundamental understanding to help us engineer biomolecules with new or improved functions," he said.

The technology covered by Enzymatics' licensing agreement is especially applicable to next-generation sequencing and could lead to the faster development of personalized medicine, the university said.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.